Related Experiment Video
Updated: Jun 11, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
High-throughput engineering and analysis of peptide binding to class II MHC
1Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Summary
Researchers developed a novel yeast-based system for high-throughput analysis of peptide binding to Major Histocompatibility Complex (MHC-II) proteins. This tool enables rapid characterization and engineering of MHC-II variants for improved understanding of adaptive immunity.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Class II major histocompatibility complex (MHC-II) proteins are crucial for adaptive immunity, presenting peptides to CD4+ T cells.
- The diversity of MHC-II alleles necessitates efficient methods for analyzing peptide binding and its impact on immunity.
- Existing experimental tools lack the high-throughput capacity for rapid and quantitative assessment of peptide-MHC-II interactions.
Purpose of the Study:
- To develop a novel, high-throughput yeast-based expression system for analyzing peptide binding to MHC-II molecules.
- To enable rapid and quantitative characterization of peptide-MHC-II interactions and facilitate engineering of MHC-II variants.
- To apply this system for mapping peptide-binding specificities and evolving novel MHC-II functionalities.
Main Methods:
- A yeast surface display system was engineered for intracellular association-dependent co-display of peptides and MHC-II molecules.
- Flow cytometry was utilized to assay the relative binding affinities of different peptides and/or MHC-II variants.
- Genetic manipulation of either peptide or MHC-II components allowed for directed evolution approaches.
Main Results:
- The system successfully enabled high-throughput, quantitative analysis of peptide binding to MHC-II.
- The tool was applied to map side-chain preferences for peptides binding to HLA-DR1.
- Novel HLA-DR1 mutants with altered peptide-binding specificities were successfully evolved using this system.
Conclusions:
- The developed yeast display system offers a powerful and versatile platform for high-throughput characterization and engineering of peptide-MHC-II interactions.
- This technology has significant implications for understanding immune responses, developing diagnostics, and designing immunotherapies.
- The system facilitates directed evolution strategies for tailoring MHC-II specificity, advancing both basic research and applied immunology.
